S&P 500 7,541.40 −0.51%
Nasdaq 25,164.36 −1.07%
S&P/TSX 35,801.09 +0.51%
Apple 338.32 −1.83%
Nvidia 202.06 −1.26%
Microsoft 507.12 −2.83%
Shopify 217.64 −1.24%
Royal Bank 286.21 +0.80%
CAD/USD 0.7157 −0.01%
CLOSED · 00:40 ET
Market ClerkRecap
Tue Nov 3 · markets closed1 signal on Nov 2128 insider buys this week · $213.6MCIRO short report next: Nov 14The week ahead

BBTX

Bambusa Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
16.00
+1.01 +6.74%
USD · close Nov 2

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
+$12M
Net, 90 days
2 / 0
Buys / sells, 90 days
2
Distinct buyers
$12M
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Nov 2Nov 2Salvia Investment GmbH · 10% ownerBuy375,000$16.00$6M
Nov 2Nov 2Jeggle Helmut Wolfgang · DirectorBuy375,000$16.00$6M

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch BBTX. Know when insiders buy.
One email the day a filing lands. Free.